Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
72.25
-3.58 (-4.72%)
At close: Mar 12, 2026, 4:00 PM EDT
73.49
+1.24 (1.72%)
After-hours: Mar 12, 2026, 4:52 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $734.07 million as of March 12, 2026. Its market cap has increased by 180.44% in one year.
Market Cap
734.07M
Enterprise Value
668.67M
1-Year Change
180.44%
Ranking
Category
Stock Price
$72.25
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $734.07M, an increase of 1,656.85%. That is a compound annual growth rate of 75.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 702.88M | 12.07% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 855.90M |
| Fortrea Holdings | 836.83M |
| Omeros | 830.24M |
| MapLight Therapeutics | 827.88M |
| CytomX Therapeutics | 826.84M |
| Kura Oncology | 817.93M |
| BridgeBio Oncology Therapeutics | 815.53M |
| MannKind | 804.14M |